Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CWAN
CWAN logo

CWAN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Clearwater Analytics Holdings Inc (CWAN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
--
1 Day change
0.04%
52 Week Range
24.560
Analysis Updated At
2026/06/26
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CWAN is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has a constructive technical setup, but the lack of a clear catalyst, no recent news, and extremely elevated options-implied volatility make this a better hold than an immediate buy. If the investor is impatient and wants to enter now, the current price is acceptable but not compelling enough to justify calling it a clear buy.

Technical Analysis

CWAN is in an overall bullish trend: SMA_5 is above SMA_20 and SMA_200, and the MACD histogram is positive and expanding, which supports upward momentum. RSI_6 at 78.607 is elevated, suggesting the stock may be extended in the short term even though it is marked neutral in the provided data. Price at 24.56 is sitting just above pivot 24.39 and near immediate resistance at 24.514 and R2 at 24.591, so upside from here looks limited in the very near term unless it breaks higher. The short-term pattern data suggests modest upside over the next month, but near-term performance is mixed.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is bearish to cautious based on put open interest being well above call open interest. The open interest put-call ratio of 1.82 indicates more downside protection or bearish positioning than bullish positioning. At the same time, option volume data is essentially absent today, so there is no strong live directional confirmation. Implied volatility is extremely high at 196.75 with IV percentile at 100 and IV rank at 170.11, which suggests the options market is pricing in a very large amount of expected movement and may be expensive for new directional bets.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
3

Positive Catalysts

  • ["Hedge funds are buying aggressively, with buying amount up 495.69% over the last quarter.", "Price trend is technically bullish with SMA_5 > SMA_20 > SMA_200.", "MACD histogram is positive and expanding, confirming upward momentum.", "Stock pattern analysis suggests a 3.48% move higher over the next month."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh catalyst driving the stock.", "Options positioning is bearish with a 1.82 put-call open interest ratio.", "Implied volatility is extremely elevated, which usually reflects uncertainty and expensive option pricing.", "RSI is elevated, indicating the stock may be extended after recent strength.", "No recent insider buying signal; insiders are neutral.", "No recent congress trading data is available."]

Financial Performance

No usable financial snapshot was provided because the latest quarter data returned an error, so I cannot assess quarterly revenue or earnings growth trends. The latest quarter season was not available in the data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no evidence here of a recent upgrade or target increase trend. Based on the available information, Wall Street appears mixed: hedge fund accumulation is a positive, but the options market leans cautious and there is no supporting analyst momentum in the dataset. There is no politician or influential figure trading data to report.

Wall Street analysts forecast CWAN stock price to rise
10 Analyst Rating
Wall Street analysts forecast CWAN stock price to rise
5 Buy
5 Hold
0 Sell
Moderate Buy
Current: 24.560
sliders
Low
24.55
Averages
27.83
High
36
Current: 24.560
sliders
Low
24.55
Averages
27.83
High
36
UBS
Buy -> Neutral
downgrade
$30
AI Analysis
2026-01-26
Reason
UBS
Price Target
$30
AI Analysis
2026-01-26
downgrade
Buy -> Neutral
Reason
UBS downgraded Clearwater Analytics to Neutral from Buy with a price target of $24.55, down from $30, after the company reached an agreement to be acquired by an investor group led by Permira and Warburg Pincus for $24.55 per share in cash.
Wells Fargo
Michael Turrin
Overweight -> Equal Weight
downgrade
$27
2026-01-08
Reason
Wells Fargo
Michael Turrin
Price Target
$27
2026-01-08
downgrade
Overweight -> Equal Weight
Reason
Wells Fargo analyst Michael Turrin downgraded Clearwater Analytics to Equal Weight from Overweight with a price target of $24.55, down from $27, following the company's agreement to be taken private at $24.55 per share by a Premira and Warburg Pincus led investor group. Wells views deal completion as highly likely.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CWAN
Unlock Now

People Also Watch